ArticleBritish journal of pharmacology2020

Fenretinide treatment accelerates atherosclerosis development in apoE-deficient mice in spite of beneficial metabolic effects.

Marco Busnelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.